Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts — Stella

View on ClinicalTrials.gov

Recruiting

Back to Warts trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Egypt

Reham Essam, Zagazig, Al Sharqia

Key details

Phase

Safety & dosing

Sponsor

Zagazig University

Enrollment target

~162 participants

Started

April 2022

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

9 Years and older

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.